Subscribe to RSS
DOI: 10.1055/s-0030-1254120
© Georg Thieme Verlag KG Stuttgart · New York
Tumoral Calcinosis of the Gluteal Region in a 14-Year-Old Girl with Juvenile Polyarthritis
Publication History
Publication Date:
21 December 2010 (online)
Introduction
Tumoral calcinosis (TC) is a rare disease characterized by uni- or multifocal calcification of soft tissues [1]. The lesions commonly develop around large joints, in particular the hip joints, shoulders and elbows, but the hand and wrist may also be affected. A single or multiple palpable tumoral masses increasing in size represent the typical clinical presentation. Restricted joint mobility and pain herald disease progression [2]. Histologically, the lesions are composed of tumor-forming lobules of amorphous calcium salt deposits within a fibrous stroma. A mixed inflammatory infiltrate rich in macrophages and occasional giant cells of the foreign-body type are commonly present at the borders of the calcifications [3].
The onset of disease is in the first and second decade of life in the majority of cases (≈80%). Although relatively rare, presentation in patients older than 50 years is well documented [2]. According to a pathogenesis-based classification of TC proposed by Smack et al. [4], three types of TC are recognized: 1) primary normophosphatemic TC; 2) primary hyperphosphatemic TC; and 3) secondary TC. Secondary TC is associated with systemic diseases known to predispose to soft tissue calcifications, in particular renal insufficiency, hyperparathyroidism, hypervitaminosis D, vitamin D deficiency and collagen vascular disease [4] [5] [6]. Recent investigations showed loss-of-function mutations in GALNT3 as a cause of primary hyperphosphatemic familial tumoral calcinosis [7]. A history of antecedent trauma was documented in some cases and possibly contributes to the development of tumoral calcinosis in predisposed individuals [8].
References
- 1 Inclan1 A, Leon1 P, Camejo1 M. Tumoral calcinosis. JAMA. 1943; 121 490-495
- 2 Longacre AM, Sheer AL. Tumoral calcinosis, case presentation and review of 55 cases in the literature. JFMA. 1974; 61 221-225
- 3 Krueger-Franke M, Siebert CH, Weiss M. et al . Tumoral calcinosis of the ischium. Arch Orthop Trauma Surg. 1992; 111 284-286
- 4 Smack D, Norton SA, Fitzpatrick JE. Proposal for a pathogenesis-based classification of tumoral calcinosis. Int J Dermatol. 1996; 35 265-271
- 5 Kannan S, Ravikumar L, Mahadevan S. et al . Tumoral calcinosis with vitamin D deficiency. Saudi J Kidney Dis Transpl. 2008; 19 960-963
- 6 Garcia S, Cofan F, Fernandez de RP. et al . Uremic tumoral calcinosis of the foot mimicking infection. Foot Ankle Int. 2002; 23 260-263
- 7 Chefetz I, Kohno K, Izumi H. et al . GALNT3, a gene associated with hyperphosphatemic familial tumoral calcinosis, is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity. Biochim Biophys Acta. 2009; 1792 61-67
- 8 McClatchie S, Bremner AD. Tumoral calcinosis – an unrecognized disease. Br Med J. 1969; 1 153-155
- 9 Braun W, Mayr E, Kundel K. et al . Tumorous calcinosis: a disease of its own?. Arch Orthop Trauma Surg. 1996; 115 53-58
- 10 Laskin WB, Miettinen M, Fetsch JF. Calcareous lesions of the distal extremities resembling tumoral calcinosis (tumoral calcinosis-like lesions): clinicopathologic study of 43 cases emphasizing a pathogenesis-based approach to classification. Am J Surg Pathol. 2007; 31 15-25
- 11 Liniger P, Slongo T, Eckhardt O. Tumoral calcinosis and atypical juvenile dermatomyositis: case report. Eur J Pediatr Surg. 1998; 8 382-384
- 12 Bittmann S, Gunther MW, Ulus H. Tumoral calcinosis of the gluteal region in a child: case report with overview of different soft-tissue calcifications. J Pediatr Surg. 2003; 38 E4-E7
- 13 Bostrom B. Tumoral calcinosis in an infant. Am J Dis Child. 1981; 135 246-247
- 14 Mitnick PD, Goldfarb S, Slatopolsky E. et al . Calcium and phosphate metabolism in tumoral calcinosis. Ann Intern Med. 1980; 92 482-487
- 15 Muller SA, Brunsting LA, Winkelmann RK. Calcinosis cutis: its relationship to scleroderma. AMA Arch Derm. 1959; 80 15-21
- 16 Lafferty FW, Reynolds ES, Pearson OH. Tumoral calcinosis: a metabolic disease of obscure etiology. Am J Med. 1965; 38 105-118
- 17 Okada T, Hara H, Shimojima H. et al . Spontaneous regression of multiple tumoral calcinosis in a child. Eur J Dermatol. 2004; 14 424-425
Correspondence
Bettina Geißler
Erlangen University Hospital
Department of Pediatric Surgery
Krankenhausstraße 12
91054 Erlangen
Germany
Phone: +49 09131 853 3296
Fax: +49 09131 853 4432
Email: bettina.geissler@uk-erlangen.de